Clinical Trials for Skyline Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Skyline Therapeutics

Clinical Trials (2)

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

83 participants

Started: Apr 2, 2024 · Completed: Mar 31, 2031

1 condition1 sponsor10 locations

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

PHASE1/PHASE2Recruiting

68 participants

Started: Feb 23, 2024 · Completed: Jan 30, 2026

1 condition1 sponsor9 locations